Cargando…

Nomogram to Predict Left Atrial Thrombus or Spontaneous Echo Contrast in Patients With Non-valvular Atrial Fibrillation

Background: The predictive power of the CHADS(2) and CHA(2)DS(2)-VASc scores for the presence of Left atrial thrombus (LAT)/ spontaneous echo contrast (SEC) in non-valvular atrial fibrillation (NVAF) is modest. The aim of this analysis is to define clinical and ultrasonic variables associated with L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhitong, Liu, Quanbo, Liu, Fei, Hidru, Tesfaldet H., Tang, Yuqi, Cong, Tao, Gao, Lianjun, Yang, Xiaolei, Xia, Yunlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551567/ https://www.ncbi.nlm.nih.gov/pubmed/34722669 http://dx.doi.org/10.3389/fcvm.2021.737551

Ejemplares similares

Development and Validation of a Nomogram for Estimation of Left Atrial Thrombus or Spontaneous Echo Contrast Risk in Non-Valvular Atrial Fibrillation Patients with Low to Borderline CHA(2)DS(2)-VASc Score
por: Li, Zhitong, et al.
Publicado: (2022)

Atrial cardiomyopathy markers predict ischemic cerebrovascular events independent of atrial fibrillation in patients with acute myocardial infarction
por: Li, Zhitong, et al.
Publicado: (2022)

Long Atrial Fibrillation Duration and Early Recurrence Are Reliable Predictors of Late Recurrence After Radiofrequency Catheter Ablation
por: Li, Zhitong, et al.
Publicado: (2022)

A nomogram to predict left atrial appendage thrombus and spontaneous echo contrast in non-valvular atrial fibrillation patients
por: Sun, Shikun, et al.
Publicado: (2022)

Does Serum Uric Acid Status Influence the Association Between Left Atrium Diameter and Atrial Fibrillation in Hypertension Patients?
por: Hidru, Tesfaldet H., et al.
Publicado: (2020)

Stress hyperglycemia ratio and neutrophil to lymphocyte ratio are reliable predictors of new-onset atrial fibrillation in patients with acute myocardial infarction
por: Pan, Lifei, et al.
Publicado: (2022)

The value of left atrial longitudinal strain in evaluating left atrial appendage spontaneous echo contrast in non-valvular atrial fibrillation
por: Ma, Chang sheng, et al.
Publicado: (2023)

Hemoglobin A1c and risk of left atrial thrombus and spontaneous echo contrast in non-valvular atrial fibrillation patients
por: Kuang, Rong-Ren, et al.
Publicado: (2017)

Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation
por: Wang, Fan, et al.
Publicado: (2018)

Left Atrial Thrombus in Patients With Non-valvular Atrial Fibrillation: A Cross-Sectional Study in China
por: Shi, Shaobo, et al.
Publicado: (2022)

The Prognostic Nutritional Index May Predict Left Atrial Appendage Thrombus or Dense Spontaneous Echo Contrast in Patients With Atrial Fibrillation
por: Wang, Zhao, et al.
Publicado: (2022)

Predictive value of red cell distribution width on left atrial thrombus or left atrial spontaneous echo contrast in patients with non-valvular atrial fibrillation
por: Zhan, Xian-Zhang, et al.
Publicado: (2018)

Associations between neutrophil-lymphocyte ratio and monocyte to high-density lipoprotein ratio with left atrial spontaneous echo contrast or thrombus in patients with non-valvular atrial fibrillation
por: Deng, Yingjian, et al.
Publicado: (2023)

Predictive value of serum uric acid on left atrial spontaneous echo contrast in non-valvular atrial fibrillation patients
por: Liao, Hong-Tao, et al.
Publicado: (2015)

Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
por: Liu, Yaowu, et al.
Publicado: (2021)

Association of inflammation indices with left atrial thrombus in patients with valvular atrial fibrillation
por: Zhou, You, et al.
Publicado: (2023)

Protective Effects of Sodium-Glucose Transporter 2 Inhibitors on Atrial Fibrillation and Atrial Flutter: A Systematic Review and Meta- Analysis of Randomized Placebo-Controlled Trials
por: Li, Daobo, et al.
Publicado: (2021)

Early atrial remodeling predicts the risk of cardiovascular events in patients with metabolic syndrome: a retrospective cohort study
por: Wali, Rohbaiz, et al.
Publicado: (2023)

Left atrial enlargement and high uric acid level are risk factors for left atrial thrombus or dense spontaneous echo contrast in atrial fibrillation patients with low to moderate embolic risk assessed by CHA(2)DS(2)-VAS(C) score
por: Tan, Chao-Di, et al.
Publicado: (2023)

Predictive value of nutritional indices for left atrial thrombus in patients with valvular atrial fibrillation
por: Zhou, You, et al.
Publicado: (2023)

Diagnostic Value of Delayed Contrast-Enhanced Cardiac Computed Tomography for Detecting Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation
por: Li, Xiang-Nan, et al.
Publicado: (2022)

Combined Effect of Homocysteine and Uric Acid to Identify Patients With High Risk for Subclinical Atrial Fibrillation
por: Wang, Shihao, et al.
Publicado: (2021)

A Study of Cardiogenic Stroke Risk in Non-valvular Atrial Fibrillation Patients
por: Song, Ziliang, et al.
Publicado: (2020)

Association of left atrial deformation indices with left atrial appendage thrombus in patients with non valvular atrial fibrillation
por: Mostafa, Shaimaa, et al.
Publicado: (2020)

A great mimic of left atrial appendage thrombus in a patient with atrial fibrillation
por: Ajmal, Muhammad, et al.
Publicado: (2021)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Sinus node dysfunction and stroke risk: a systematic review and meta-analysis
por: Dong, Haoyu, et al.
Publicado: (2023)

Quantitative acetylated proteomics on left atrial appendage tissues revealed atrial energy metabolism and contraction status in patients with valvular heart disease with atrial fibrillation
por: Tu, Tao, et al.
Publicado: (2022)

Left atrial enlargement and non-paroxysmal atrial fibrillation as risk factors for left atrial thrombus/spontaneous Echo contrast in patients with atrial fibrillation and low CHA(2)DS(2)-VASc score
por: Lin, Wei-Dong, et al.
Publicado: (2020)

Incidence of atrial functional tricuspid regurgitation and its correlation with tricuspid valvular deformation in patients with persistent atrial fibrillation
por: Yamamoto, Yuko, et al.
Publicado: (2022)

Population pharmacokinetic analysis for dabigatran etexilate in Chinese patients with non-valvular atrial fibrillation
por: Liu, Ya-ou, et al.
Publicado: (2022)

Percutaneous left atrial appendage closure using the LAmbre device in patients with atrial fibrillation and left atrial appendage thrombus
por: Jin, Lu-Shen, et al.
Publicado: (2022)

Expression Profiles of Circular RNA in Human Atrial Fibrillation With Valvular Heart Diseases
por: Zhu, Xiyu, et al.
Publicado: (2020)

Risk factors for left atrial thrombus in younger patients (aged < 65 years) with atrial fibrillation or atrial flutter: Data from the multicenter left atrial thrombus on transesophageal echocardiography (LATTEE) registry
por: Uziȩbło-Życzkowska, Beata, et al.
Publicado: (2022)

Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Hu, Bo, et al.
Publicado: (2021)

Left Atrial Spontaneous Echo Contrast and Ischemic Stroke in Patients Undergoing Percutaneous Left Atrial Appendage Closure
por: Wang, Binhao, et al.
Publicado: (2021)

Detection of left atrial appendage thrombus by dual-energy computed tomography-derived imaging biomarkers in patients with atrial fibrillation
por: Li, Wenhuan, et al.
Publicado: (2022)

Editorial to “The differences of atrial thrombus locations and variable response to anticoagulation in non‐valvular atrial fibrillation with ventricular cardiomyopathy”
por: Chung, Wei‐Hsin, et al.
Publicado: (2020)

A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
por: Shang, Luxiang, et al.
Publicado: (2021)

Economic and Clinical Impact of Stroke and Warfarin Use for Patients with Non-valvular Atrial Fibrillation
por: Wang, Li, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_p2221rsi6778hu8riqi6fhefqa